Results 131 to 140 of about 1,056 (174)

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Nemolizumab Treatment Normalizes Dysregulated Microbiome in Lesional Prurigo Nodularis

Journal of Investigative Dermatology
Ruiwen Zhou, Prasad Chaskar, Matthew T. Patrick, Kai Wang, Christophe Piketty, Valerie Julia, Johann E. Gudjonsson, Jayendra Kumar Krishnaswamy, Lam C. Tsoi   +8 more
openaire   +2 more sources

Atopic Dermatitis Beyond the Skin Barrier: Precision Medicine Approaches to Immunological Profiling and Therapeutic Innovation. [PDF]

Int J Mol Sci
Galatis V, Siloși I, Assani MZ, Boldeanu L, Mitroi GG, Boldeanu MV.   +5 more
europepmc   +1 more source

Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety. [PDF]

Curr Ther Res Clin Exp
Masoumi N, Monadi T, Aminzade Z, Soltani A, Noqani H, Enderami SE.   +5 more
europepmc   +1 more source

nemolizumab（抗IL-31抗体）

Japanese Journal of Allergology, 2019
openaire   +1 more source